Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 28/2/2020
SIETES contiene 92917 citas

 
 
 1 a 20 de 62 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. FDA grants experimental Huntington’s disease orphan drug status. DIA Daily 2016:1. [Ref.ID 100438]
2. Cita con resumen
Owen J. Pay drug companies $1bn for each new antibiotic, says report. BMJ 2016;353:i2863. [Ref.ID 100427]
3. Cita con resumen
Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim S. Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts. JAMA Intern Med 2016;176:junio. [Ref.ID 100237]
4. Cita con resumen
Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B. Safer prescribing - A trial of education, informatics, and financial incentives. N Engl J Med 2016;374:1053-64. [Ref.ID 100156]
5. Cita con resumen
Kmietowicz Z. Doctors condemn “unethical” £55 payment for every new dementia diagnosis. BMJ 2014;349:g6424. [Ref.ID 98291]
6. Cita con resumen
Anónimo. Swiss vaccine to treat Ebola approved for human trials. DIA Daily 2014:29 de octubre. [Ref.ID 98238]
7. Cita con resumen
Weaver T, Metreblan N, Hellier J, Pillig S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O, Dunn J, Glasper A, Finch E, Strang J. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet 2014;384:153-63. [Ref.ID 97813]
8.Tiene citas relacionadas Cita con resumen
Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, David AS, O'Connell N, Forrest A, Burns T. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ 2013;347:11. [Ref.ID 96428]
9.Tiene citas relacionadas
Kendall T. Paying people with psychosis to improve adherence. BMJ 2013;347:9. [Ref.ID 96426]
10. Cita con resumen
Morden NE, Schwartz LM, Fisher ES, Woloshin S. Accountable prescribing. N Engl J Med 2013;369:299-302. [Ref.ID 95875]
11. Cita con resumen
Anónimo. Rémunération sur résultats: objectifs de soins et de coûts (nº 14 à nº 24). Prescrire 2013;33:456-63. [Ref.ID 95578]
12.
Glasziou PP, Buchan H, Del Mar C, Doust J, Harris M, Knight R, Scott A, Scott IA, Strockwell A. Pay for performance. How to make it worth doing. BMJ 2012;345:22-5. [Ref.ID 93602]
13.Tiene citas relacionadas Cita con resumen
Hoffman SJ, Pogge T, Hollis A. New drug development. Lancet 2011;377:901-2. [Ref.ID 90325]
14.
Kesselheim AS. Using market-exclusivity incentives to promote pharmaceutical innovation. N Engl J Med 2010;363:1855-62. [Ref.ID 89608]
15. Cita con resumen
Vicens Caldentey C, Sempere Verdú E, Arroyo Aniés MP, Hernández Rodríguez MA, Palop Larrea V, Orueta Sánchez R, Baos Vicente V. Variabilidad en la medición de la calidad de prescripción por comunidades autónomas. Aten Primaria 2010;42:380-7. [Ref.ID 89142]
16. Cita con resumen
Young RC. Cancer clinical trials - A chronic but curable crisis. N Engl J Med 2010;363:306-9. [Ref.ID 88945]
17. Cita con resumen
Dyer C. Incentives to GPs to prescribe generics may breach EU law. BMJ 2010;340:828. [Ref.ID 88336]
18. Cita con resumen
Richard Gold E, Kaplan W, Orbinski J, Harland-Logan S, S-Marandi N. Are patents impeding medical care and innovation?. PLOS Medicine 2010;7:208. [Ref.ID 87645]
19. Cita con resumen
Anderson T. Novartis under fire for accepting new reward for old drug. Lancet 2009;373:1414. [Ref.ID 85712]
20. Cita con resumen
Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009;360:699-709. [Ref.ID 85244]
Seleccionar todas
 
 1 a 20 de 62 siguiente >>